UST Co., Ltd. (KOSDAQ:263770)
1,626.00
-28.00 (-1.69%)
At close: Sep 23, 2026
UST Co., Ltd. Revenue
UST Co., Ltd. had revenue of 18.30B KRW in the quarter ending June 30, 2026, with 32.00% growth. This brings the company's revenue in the last twelve months to 64.19B, up 2.56% year-over-year. In the year 2025, UST Co., Ltd. had annual revenue of 57.97B, down -20.81%.
Revenue (ttm)
64.19B
Revenue Growth
+2.56%
P/S Ratio
0.60
Revenue / Employee
n/a
Employees
n/a
Market Cap
38.54B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 57.97B | -15.24B | -20.81% |
| Dec 31, 2024 | 73.20B | -25.94B | -26.16% |
| Dec 31, 2023 | 99.14B | -748.61M | -0.75% |
| Dec 31, 2022 | 99.89B | 33.82B | 51.19% |
| Dec 31, 2021 | 66.07B | 15.34B | 30.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sewon Co.,Ltd | 244.53B |
| Seung Il | 145.86B |
| Hizeaero | 93.82B |
| Kyung Nam Pharm | 54.89B |
| Assems | 54.44B |
| Eagle Veterinary Technology Co.,Ltd | 44.73B |
| Bonne | 42.19B |
| Kolmar BioTech | 40.30B |